New drug eases stomach pain in clinical trial

NCT ID NCT05248802

Completed Symptom relief Sponsor: Dexa Medica Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called DLBS2411 in 106 adults with functional dyspepsia, a condition causing stomach pain and fullness without a clear cause. Participants took either the drug or a placebo twice daily for 4 weeks. The goal was to see if the drug improves quality of life by reducing symptoms like pain and bloating.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia functional gastric disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FUNCTIONAL DYSPEPSIA

Contacts and locations

Locations

Department of Internal Medicine, Budhi Asih Hospital

Jakarta, DKI Jakarta, Indonesia
Department of Internal Medicine, Dr. Kariadi General Hospital

Semarang, Central Java, Indonesia
Department of Internal Medicine, Dr. Moewardi Hospital

Surakarta, Central Java, Indonesia
Department of Internal Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia

Surabaya, East Java, Indonesia
Department of Internal Medicine, Fatmawati General Hospital

Jakarta, DKI Jakarta, Indonesia
Department of Internal Medicine, Pasar Rebo Hospital

Jakarta, DKI Jakarta, Indonesia
Department of Internal Medicine, Universitas Sebelas Maret (UNS) Hospital

Sukoharjo, Central Java, Indonesia
Division of Gastroenterology Department of Internal Medicine Faculty of Medicine, University of Indonesia Dr. Cipto Mangunkusumo National General Hospital

Jakarta, Jakarta Special Capital Region, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.